Anti-diabetic Agents (oral)

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

• Revision history
  • October 21, 2022; September 2020; September 2018; September 2016; August 2014; July 2014; October 2012; January 2011; February 2008; November 2007; June 2003; July 2002; September 2001; June 2001; June 2000; July 1999; June 1998; June 1997; June 1996; September 1995. 
• Initially developed
  • April 1994